Upon completion of the acquisition, Inspirata’s Dynamyx digital pathology technology, employees and customers will become part of the Fujifilm business, according to a Dec. 19 release from Fujifilm.
The aim of the deal is to bolster the company’s Synapse imaging product to combine images and patient data in electronic health records to improve services for oncology patients.
